{"id":"W4200232423","doi":"10.1186/s12962-021-00329-w","title":"First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis","year":2021,"lang":"en","type":"article","venue":"Cost Effectiveness and Resource Allocation","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"Natural Science Foundation of Hunan Province; National Natural Science Foundation of China","keywords":"Medicine; Pembrolizumab; Lung cancer; Oncology; Public health; Health services research; Chemotherapy; Health administration; Health economics; Quality of Life Research; Stage (stratigraphy); Internal medicine; Cost effectiveness; Cancer; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006722457,0.001207417,0.002311564,0.002525276,0.0002138038,0.001636876,0.001018392,0.0009522902,0.004864056],"category_scores_gemma":[0.01166746,0.0007411795,0.007522231,0.002296339,0.0002965446,0.0009705639,0.0007915341,0.001107073,0.0002320446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004385837,"about_ca_system_score_gemma":0.002415811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01682479,"about_ca_topic_score_gemma":0.01253085,"domain_scores_codex":[0.9961755,0.002962576,0.0001503046,0.0002378455,0.0003027714,0.0001708703],"domain_scores_gemma":[0.9953303,0.003498959,0.0005335309,0.0001609797,0.0003108584,0.0001652678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.02127829,0.001593014,0.04663852,0.006231435,0.0376643,0.0007949402,0.0001134197,0.7869734,0.00125929,0.01015842,0.01349014,0.0738048],"study_design_scores_gemma":[0.007261768,0.005255924,0.06577129,0.003057897,0.04502749,0.001280579,0.0003361745,0.8474562,0.001152954,0.0100894,0.0130678,0.0002425058],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8496395,0.08821522,0.01883526,0.004302721,0.0003799389,0.001797485,0.02109852,0.0002182243,0.01551309],"genre_scores_gemma":[0.9828058,0.005367508,0.004511811,0.0004907411,0.00006074161,0.0004133168,0.005738556,0.00002134052,0.0005903079],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01682479,"threshold_uncertainty_score":0.03555214,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03294104266757879,"score_gpt":0.3588166846572327,"score_spread":0.3258756419896539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}